We are live on ! Find out more
NBTX

Nanobiotix

11 hedge funds and large institutions have $81.3M invested in Nanobiotix in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14.78% more ownership

Funds ownership: 0%14.78% (+15%)

Holders
11
Holders Change
+11
Holders Change %
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$23.1M +$24.1M +1,400,000 New
PA
2
Perceptive Advisors
New York
$18.1M +$19M +1,100,000 New
AG
3
Artal Group
Luxembourg
$16.5M +$17.2M +1,000,000 New
TCM
4
Tybourne Capital Management
Hong Kong
$12.4M +$12.9M +750,000 New
O
5
OrbiMed
New York
$8.25M +$8.61M +500,000 New
WP
6
Woodline Partners
California
$1.16M +$1.21M +70,000 New
Millennium Management
7
Millennium Management
New York
$780K +$814K +47,261 New
Citadel Advisors
8
Citadel Advisors
Florida
$537K +$561K +32,556 New
MIM
9
Monashee Investment Management
Massachusetts
$248K +$258K +15,000 New
Morgan Stanley
10
Morgan Stanley
New York
$190K +$198K +11,490 New
UBS Group
11
UBS Group
Switzerland
$6K +$5.96K +346 New

NBTX Hedge Fund Activity: Q4 2020 in Review

11 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q4 2020, worth a combined $81.3M.

Buyers outnumbered sellers: 11 funds opened new NBTX positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baillie Gifford & Co, opening a new position worth an estimated $24.1M.

  • 11 institutional investors held Nanobiotix (NBTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $81.3M of Nanobiotix stock for Q4 2020.
  • 11 funds opened new Nanobiotix positions in Q4 2020 and 0 closed out, a net change of +11 holders.
  • The largest Nanobiotix buyer in Q4 2020 was Baillie Gifford & Co, an estimated $24.1M added.

Based on aggregated 13F filings for Q4 2020.